Home
About us
Editorial board
Ahead of print
Browse Articles
Search
Submit article
Instructions
Subscribe
Contacts
Login
Advanced Search
Users Online: 1409
» Articles published in the past year
To view other articles click corresponding year from the navigation links on the left side.
All
|
Case Report
|
Case Reports
|
Editorial
|
Erratum
|
Letter To Editor
|
Letters to Editor
|
Mini Review
|
Notice of Retraction
|
Original Article
|
Original Articles
|
Review Article
|
Review Articles
|
Short Communication
|
Short Communications
|
Systematic Review
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Original Article:
Clinical, laboratory and imaging characteristics, and outcomes of hospitalized children with suspected COVID-19 infection: A report from Isfahan-Iran
Hamid Rahimi, Zahra Pourmoghaddas, Marzieh Aalinezhad, Fariba Alikhani, Rana Saleh, Sheida Amini, Saman Tavakoli, Shima Saeidi, Narges Sharifi, Silva Hovsepian
J Res Med Sci
2022, 27:27 (17 March 2022)
DOI
:10.4103/jrms.jrms_815_21
Background:
The aim of this study was to evaluate the clinical, laboratory and imaging characteristics, and outcomes of hospitalized children with suspected COVID-19 infection in Isfahan.
Materials and Methods:
In this cross-sectional study, all children aged < 15 years, who hospitalized as suspected case of COVID-19 were enrolled. During this study, all demographic, clinical, laboratory, and imaging characteristics as well as follow-up data and outcomes of the hospitalized children were recorded by pediatric residents using a questionnaire. The findings of studied populations in the two groups of definite/or suspected and negative COVID-19 patients were compared.
Results:
During 6 months' period, 137 children with suspected COVID-19 infection were evaluated. Mean age of studied population was 4.3 (0.38) years. The most common symptoms in order were fever, cough, dyspnea and diarrhea. The most common computed tomography scan findings were bilateral ground glass and subpleural involvements. The rate of mortality was 7.3%. COVID-19 polymerase chain reaction test was positive in 22% of the patients. Based on the specialist's diagnosis, 30/25 patients were definite/or suspected to COVID-19 and reminder (79) were negative. O2 saturation <90%, was significantly higher in children with definite/or suspected diagnosis for COVID-19 (46.7% vs. 22.4%,
P
< 0.05). Dyspnea and shivering were significantly higher in children with definite/or suspected diagnosis for COVID-19 than those negative for COVID-19(
P
< 0.05).Mean duration of hospitalization was significantly associated with level of lactate dehydrogenase (
P
< 0.05).
Conclusion:
The clinical, laboratory, and imaging findings of our studied population were similar to other studies, but outcome was not similar which may be due to our studied population (inpatients cases). It is suggested that a better understanding of the infection in children may give important insights into disease pathogenesis, health-care practices, and public health policies.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Original Article:
The effect of COVID 19 on liver parenchyma detected and measured by CT scan hounsfield units
Jehad Z Fataftah, Raed Tayyem, Haitham Qandeel, Haneen A Baydoun, Abdel Rahman A Al Manasra, Ahmad Tahboub, Salem Y Al-Dwairy, Alaa Al-Mousa
J Res Med Sci
2022, 27:26 (17 March 2022)
DOI
:10.4103/jrms.JRMS_1228_20
Background:
COVID 19 may affect organs other than lungs, including liver, leading to parenchymal changes. These changes are best assessed by unenhanced computed tomography (CT). We aim to investigate the effect of COVID 19 on liver parenchyma by measuring the attenuation in CT scan Hounsfield unit (HU).
Materials and Methods:
A cohort of patients, who tested COVID 19 polymerase chain reaction positive, were enrolled and divided into two groups: fatty liver (FL) group (HU ≤ 40) and nonfatty liver (NFL) group (HU > 40) according to liver parenchyma attenuation measurements by high resolution noncontrast CT scan. The CT scan was performed on admission and on follow up (10–14 days later). Liver enzyme tests were submitted on admission and follow up.
Results:
Three hundred and two patients were enrolled. Liver HU increased significantly from 48.9 on admission to 53.4 on follow up CT scan (P<0.001) in all patients. This increase was more significant in the FL group (increased from 31.9 to 42.9 [P =0.018]) Liver enzymes were abnormal in 22.6% of the full cohort. However, there was no significant change in liver enzymes between the admission and follow up in both groups.
Conclusion:
The use of unenhanced CT scan for assessment of liver parenchymal represents an objective and noninvasive method. The significant changes in parenchymal HU are not always accompanied by significant changes in liver enzymes. Increased HU values caused by COVID 19 may be due to either a decrease in the fat or an increase in the fibrosis in the liver.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Original Article:
Metabolic effects of adding Topiramate on Aripiprazole in bipolar patients aged between 6-18 years, a randomized, double-blind, placebo-controlled trial
Soroor Arman, Mostafa Haghshenas
J Res Med Sci
2022, 27:23 (17 March 2022)
DOI
:10.4103/jrms.jrms_672_21
Background:
second-generation antipsychotics (SGAs) are associated with metabolic side effects in child and adolescents. The aim of this study is to evaluate the metabolic effects of adding topiramate on aripiprazole in patients with bipolar disorder (BD) aged between 6 and 18 years.
Materials and Methods:
A 12-week, double-blind, placebo-controlled, randomized trial was conducted in the child psychiatric units of university hospitals. Forty patients aged between 6 and 18 years with new diagnosis of BD participated in the study. Eleven patients were excluded. Subjects received aripiprazole plus topiramate (Group 1,
n
= 15) or aripiprazole (Group 2,
n
= 14) for a 3-month period. Young mania rating scale (YMRS) was used for measuring the manic symptoms severity. Primary outcome measures included weight, height, body mass index (BMI), waist circumference, abdominal circumference, and blood pressure. Secondary outcome measures included fasting blood glucose, hemoglobin A1C, fasting insulin, and fasting lipid profile. Changes in metabolic profile during the study were obtained by using repeated measures of variance.
Results:
During a 3-month follow-up, YMRS measures decreased significantly in both groups with a significant difference between groups (
P
< 0.05). The mean of weight, BMI, and high-density lipoprotein levels in group 2 were significantly increased (
P
< 0.05), and the mean of low-density lipoprotein level in group 1 was decreased (
P
< 0.05). No significant differences were observed in anthropometric parameters and metabolic indices between groups (
P
> 0.05).
Conclusion:
Adding topiramate on aripiprazole is effectivefor controlling bipolar disorder as well as metabolic adverse effects of SGAs in juvenile patients.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Original Article:
Effects of the COVID-19 pandemic on lifestyle among Iranian population: A multicenter cross-sectional study
Abdurrahman Charkazi, Fatemeh Salmani, Mitra Moodi, Ensiyeh Norozi, Fatemeh Zarei, Masoud Lotfizadeh, Mohamamd Taghi Badeleh, Azita Noroozi, Shirin Shahbazi Sighaldeh, Yusef Dadban-Shahamat, Mohammad Ali Orouji, Maryam Ahmadi-Livani, Arezoo Foroughi, Amrollah Sharifi, Mehran Akbari, Zoya Tahergorabi
J Res Med Sci
2022, 27:22 (17 March 2022)
DOI
:10.4103/jrms.jrms_506_21
Background:
Quarantine, an unpleasant experience, was implemented in many countries to limit the spread of Coronavirus disease 2019 (COVID-19), which it could associated whit lifestyle changes. The present study aimed to determine the changes in Iranian's lifestyle during COVID-19 pandemic.
Materials and Methods:
In the present cross-sectional study, 2710 Iranian people completed an online researcher-made questionnaire asking lifestyle regarding COVID-19, which includes five sections about physical activity, stress and anxiety, nutrition habit, sleep disorders, and interpersonal relationship in addition to demographic data from January to February 2021, using the multistage cluster sampling method.
Results:
The participants' mean age was 33.78 ± 11.50 years and 68.3% of them were female. Traveling, sightseeing, and family visits have been eliminated from 91%, 83.5%, and 77.5% of participants' lives, respectively. There were increase in stress level (
P
< 0.001), weight of the participants (
P
< 0.001), sleep problems (
P
< 0.001), and healthier foods (
P
< 0.001) but decrease in interpersonal communication (
P
< 0.001) and the amount of physical activity (
P
< 0.001).
Conclusion:
In summary, this study indicates some changes in lifestyle of Iranian people, including changes in some eating practices, physical activity, social communication, and sleeping habits during the pandemic. However, as the COVID-19 pandemic is ongoing, a comprehensive understanding of these behaviors and habits can help develop interventions to mitigate the negative lifestyle behaviors during COVID-19 pandemic.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Original Article:
High claudin-4 antigen expression in triple-negative breast cancer by the immunohistochemistry method
Azar Naimi, Nadereh Zare, Elham Amjadi, Maryam Soltan
J Res Med Sci
2022, 27:20 (17 March 2022)
DOI
:10.4103/jrms.jrms_1389_20
Background:
Triple-negative breast cancer is a heterogeneous subtype of breast cancer. Claudin is an epithelial tight junctional protein, and also it is a receptor for clostridium perfringens enterotoxin and shows impairment of expression in several cancers. The chief purpose of this study is to assess the claudin-4 expression in triple-negative breast cancer (TNBC) Iranian patients and evaluate its correlation with some clinicopathological factors.
Materials and Methods:
In this study, 81 TNBC patients were evaluated for the claudin-4 expression by immunohistochemistry. The slides' staining intensity was examined and scored from 0 to 3. Then, slides were reviewed to assess the percentage of cells with membrane and cytoplasmic staining; the obtaining scores were 1–4. Finally, added the resulting two numbers from two stages, and the final number was a maximum of 7. Final scores of 0–3 were considered the low expression, and 4–7 were considered the high expression. Finally, the collected data were analyzed using the Chi-square test.
Results
: Eighty-one women with breast cancer and a mean age of 49 ± 12 years participated in the study. In 80% of the patients, there was a high expression of claudin-4 marker, and 20% had low expression. The expression level of the marker was not significantly correlated with age, tumor size, lymph node involvement, tumor grade, disease stage, Ki-67, and metastasis.
Conclusion:
The present study confirmed the high frequency of claudin-4 antigen expression in TNBC patients, and no significant correlation was observed between the expression of antigen and demographic or clinicopathological factors.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Original Article:
Influential factors on survival in gastric cancer: A single-center study
Ghodratollah Roshanaei, Azadeh Kiumarsi, Amir Kasaeian, Malihe Safari, Mohammad Abbasi, Ali Rahimi
J Res Med Sci
2022, 27:19 (17 March 2022)
DOI
:10.4103/jrms.JRMS_1286_20
Background:
Gastric cancer (GC) is one of the conspicuous causes of cancer-related death worldwide. Considering the mounting incidence of this cancer in developing countries such as Iran, determining the influential factors on the survival of involved patients is noteworthy. Hence, we aimed to ascertain the survival rates and the prognostic factors in our GC patients.
Materials and Methods:
In this retrospective cohort study, data of 314 patients with GC in a referral cancer center in Hamadan province of Iran were studied. The outcome of our study was survival time and the influential factors were gender, age at diagnosis, tumor history, tumor grade, surgery history, radiotherapy history, stage of disease, metastasis history, and lymph node involvement. Kaplan − Meier method and log-rank test were used for the calculation and comparing the survival curves and Cox-proportional hazard model was used for the multivariable analysis of prognostic factors.
Results:
In a total of 314 GC patients, the median age at the diagnosis was 63 years (range: 21–92) with most patients (74.84%) being males. The median follow-up time was 2.42 years, and the median survival time was 2 years. The multivariable cox analysis of overall survival (OS) indicated that having distant metastasis increased the hazard of death by about 2.5 times (
P
< 0.0001, heart rates [HR]: 2.53, 95% confidence interval [CI]: [1.71, 3.75]), and receiving surgery as treatment, decreased the hazard of death up to 36% (
P
= 0.02, HR: 0.64, 95%CI: [0.46–0.89]). The other variables did not have any significant effects on the OS.
Conclusion:
The results of this study showed that lower survival (greater hazard of death) strongly and significantly associated with having distant metastasis in patients with GC and receiving surgery could significantly decrease the hazard of death in these patients instead.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Advanced Search
Month wise articles
Figures next to the month indicate the number of articles in that month
2023
March
[
3
]
February
[
2
]
January
[
3
]
2022
December
[
4
]
November
[
5
]
September
[
6
]
August
[
6
]
July
[
6
]
June
[
4
]
May
[
4
]
April
[
6
]
March
[
6
]
February
[
8
]
January
[
7
]
2021
November
[
5
]
October
[
9
]
September
[
6
]
August
[
11
]
July
[
5
]
June
[
4
]
May
[
4
]
March
[
2
]
February
[
5
]
January
[
7
]
2020
December
[
5
]
November
[
4
]
October
[
7
]
September
[
6
]
August
[
5
]
July
[
5
]
June
[
5
]
May
[
7
]
April
[
7
]
March
[
8
]
February
[
6
]
January
[
8
]
2019
December
[
6
]
November
[
6
]
October
[
6
]
September
[
5
]
August
[
4
]
July
[
11
]
June
[
5
]
May
[
9
]
April
[
5
]
March
[
5
]
February
[
6
]
January
[
5
]
2018
December
[
7
]
November
[
6
]
October
[
4
]
September
[
5
]
August
[
6
]
July
[
7
]
June
[
6
]
May
[
8
]
March
[
3
]
February
[
6
]
January
[
6
]
2017
December
[
4
]
November
[
2
]
June
[
7
]
1900
January
[
1
]
Sitemap
|
What's New
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
© Journal of Research in Medical Sciences | Published by Wolters Kluwer -
Medknow
Online since 9
th
February, 2015